Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Comparison of Prognostic Value of 10 Biochemical Indices at Admission for Prediction Postoperative Myocardial Injury and Hospital Mortality in Patients with Osteoporotic Hip Fracture

dc.contributor.authorFisher, Alexander
dc.contributor.authorSrikusalanukul, Wichat
dc.contributor.authorFisher, Leon
dc.contributor.authorSmith, Paul
dc.date.accessioned2024-07-22T01:28:56Z
dc.date.available2024-07-22T01:28:56Z
dc.date.issued2022
dc.date.updated2024-05-19T08:16:49Z
dc.description.abstractAim: To evaluate the prognostic impact at admission of 10 biochemical indices for prediction postoperative myocardial injury (PMI) and/or hospital death in hip fracture (HF) patients. Methods: In 1273 consecutive patients with HF (mean age 82.9 ± 8.7 years, 73.5% women), clinical and laboratory parameters were collected prospectively, and outcomes were recorded. Multiple logistic regression and receiver-operating characteristic analyses (the area under the curve, AUC) were preformed, the number needed to predict (NNP) outcome was calculated. Results: Age ≥ 80 years and IHD were the most prominent clinical factors associated with both PMI (with cardiac troponin I rise) and in-hospital death. PMI occurred in 555 (43.6%) patients and contributed to 80.3% (49/61) of all deaths (mortality rate 8.8% vs. 1.9% in non-PMI patients). The most accurate biochemical predictive markers were parathyroid hormone > 6.8 pmol/L, urea > 7.5 mmol/L, 25(OH)vitamin D < 25 nmol/L, albumin < 33 g/L, and ratios gamma-glutamyl transferase (GGT) to alanine aminotransferase > 2.5, urea/albumin ≥ 2.0 and GGT/albumin ≥ 7.0; the AUC for developing PMI ranged between 0.782 and 0.742 (NNP: 1.84–2.13), the AUC for fatal outcome ranged from 0.803 to 0.722, (NNP: 3.77–9.52). Conclusions: In HF patients, easily accessible biochemical indices at admission substantially improve prediction of hospital outcomes, especially in the aged >80 years with IHD.
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn2077-0383
dc.identifier.urihttps://hdl.handle.net/1885/733714049
dc.language.isoen_AUen_AU
dc.provenanceThis article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
dc.publisherM D P I AG
dc.rights© 2022 The authors
dc.rights.licenseCreative Commons Attribution licence
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceJournal of Clinical Medicine
dc.subjecthip fracture
dc.subjectmortality
dc.subjectmyocardial injury
dc.subjectbiochemical markers
dc.subjectpredictors
dc.titleComparison of Prognostic Value of 10 Biochemical Indices at Admission for Prediction Postoperative Myocardial Injury and Hospital Mortality in Patients with Osteoporotic Hip Fracture
dc.typeJournal article
dcterms.accessRightsOpen Access
local.bibliographicCitation.issue22
local.contributor.affiliationFisher, Alexander, College of Health and Medicine, ANU
local.contributor.affiliationSrikusalanukul, Wichat, Canberra Hospital
local.contributor.affiliationFisher, Leon, Frankston Hospital
local.contributor.affiliationSmith, Paul, College of Health and Medicine, ANU
local.contributor.authoruidFisher, Alexander, u5097581
local.contributor.authoruidSmith, Paul, u1496431
local.description.notesImported from ARIES
local.identifier.absfor320101 - Cardiology (incl. cardiovascular diseases)
local.identifier.absfor320216 - Orthopaedics
local.identifier.absseo200105 - Treatment of human diseases and conditions
local.identifier.ariespublicationa383154xPUB37692
local.identifier.citationvolume11
local.identifier.doi10.3390/jcm11226784
local.identifier.scopusID2-s2.0-85142646920
local.publisher.urlhttps://www.mdpi.com/
local.type.statusPublished Version

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
jcm-11-06784-v2.pdf
Size:
902.96 KB
Format:
Adobe Portable Document Format